Filtros de búsqueda

Lista de obras de Ezra E Cohen

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

A Mechanism-Based Approach to the Management of Osteoarthritis Pain

artículo científico publicado en 2015

A Novel Peptide for Simultaneously Enhanced Treatment of Head and Neck Cancer and Mitigation of Oral Mucositis

artículo científico publicado en 2016

A Threshold Model for T-Cell Activation in the Era of Checkpoint Blockade Immunotherapy

A disturbance in the force--mitochondrial mutations in squamous cell carcinoma of the head and neck

scientific article published on 01 August 2007

A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle

artículo científico publicado en 2009

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers

artículo científico publicado en 2010

A pharmacodynamic study of sirolimus and metformin in patients with advanced solid tumors

artículo científico publicado en 2018

A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer

artículo científico publicado en 2017

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

artículo científico publicado en 2013

A phase I trial of docetaxel based induction and concomitant chemotherapy in patients with locally advanced head and neck cancer

artículo científico publicado en 2007

A phase II study of ABT-751 in patients with advanced non-small cell lung cancer

scientific article published on 01 June 2008

A phase II study of lapatinib in recurrent/metastatic squamous cell carcinoma of the head and neck.

artículo científico publicado en 2012

A phase II trial of perifosine, an oral alkylphospholipid, in recurrent or metastatic head and neck cancer.

artículo científico publicado en 2006

A phase Ib study of utomilumab (PF-05082566) in combination with mogamulizumab in patients with advanced solid tumors

scientific article published on 04 December 2019

A phase Ib trial of LY2584702 tosylate, a p70 S6 inhibitor, in combination with erlotinib or everolimus in patients with solid tumours

artículo científico publicado en 2014

A qualitative evaluation of the validity of published health utilities and generic health utility measures for capturing health-related quality of life (HRQL) impact of differentiated thyroid cancer (DTC) at different treatment phases

artículo científico publicado en 2014

A randomized validation study comparing embedded versus extracted FACT Head and Neck Symptom Index scores

artículo científico publicado en 2007

Active8: a randomized, double-blind, placebo-controlled study of chemotherapy plus cetuximab in combination with TLR8 agonist VTX-2337 in patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN).

artículo científico publicado en 2014

Activity of XL184 (Cabozantinib), an Oral Tyrosine Kinase Inhibitor, in Patients With Medullary Thyroid Cancer ⬇️

artículo científico publicado el 23 de mayo de 2011

Adjuncts for the evaluation of potentially malignant disorders in the oral cavity: Diagnostic test accuracy systematic review and meta-analysis-a report of the American Dental Association

artículo científico publicado en 2017

Adjuvant chemoradiotherapy for locoregionally advanced and high-risk salivary gland malignancies ⬇️

artículo científico publicado el 26 de julio de 2011

Adjuvant chemotherapy prior to postoperative concurrent chemoradiotherapy for locoregionally advanced head and neck cancer ⬇️

artículo científico publicado el 9 de octubre de 2010

Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial

artículo científico publicado en 2019

Afatinib efficacy against squamous cell carcinoma of the head and neck cell lines in vitro and in vivo

artículo científico publicado en 2015

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

artículo científico publicado en 2015

Afatinib versus placebo as adjuvant therapy after chemoradiation in a double-blind, phase III study (LUX-Head & Neck 2) in patients with primary unresected, clinically intermediate-to-high-risk head and neck cancer: study protocol for a randomized c

artículo científico publicado en 2014

Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial

scientific article published on 13 June 2019

Airway management before chemoradiation for advanced head and neck cancer ⬇️

artículo científico publicado el 7 de marzo de 2011

American Cancer Society Head and Neck Cancer Survivorship Care Guideline

artículo científico publicado en 2016

An attenuated adenovirus, ONYX-015, as mouthwash therapy for premalignant oral dysplasia.

artículo científico publicado en 2003

An open-label single-arm, phase II trial of zalutumumab, a human monoclonal anti-EGFR antibody, in patients with platinum-refractory squamous cell carcinoma of the head and neck

artículo científico

Analysis of further disease progression in metastatic non-small cell lung cancer: implications for locoregional treatment

artículo científico publicado en 2004

Anti-tubulin drugs conjugated to anti-ErbB antibodies selectively radiosensitize

artículo científico publicado en 2016

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer

artículo científico publicado en 2014

Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study

artículo científico publicado en 2008

B-cells improve overall survival in HPV-associated squamous cell carcinomas and are activated by radiation and PD-1 blockade

artículo científico publicado en 2020

Cabozantinib for the Treatment of Advanced Medullary Thyroid Cancer ⬇️

artículo científico publicado el 25 de octubre de 2012

Cabozantinib in progressive medullary thyroid cancer

artículo científico publicado en 2013

Carboplatin plus vinorelbine with concomitant radiation therapy in advanced non-small cell lung cancer: a phase I study

artículo científico publicado en 2002

Characteristics associated with swallowing changes after concurrent chemotherapy and radiotherapy in patients with head and neck cancer

artículo científico publicado en 2008

Chemoradiation for patients with advanced oral cavity cancer

artículo científico publicado en 2010

Chemoradiation for patients with large‐volume laryngeal cancers ⬇️

artículo científico publicado el 3 de noviembre de 2011

Clinical Cancer Advances 2016: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

artículo científico publicado en 2016

Clinical Cancer Advances 2019: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology

artículo científico publicado en 2019

Comparing programmed death ligand 1 scores for predicting pembrolizumab efficacy in head and neck cancer

artículo científico publicado en 2020

Considering the survivorship care needs of head and neck cancer survivors.

artículo científico publicado en 2016

Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer

artículo científico publicado en 2016

Corrigendum: PI3Kγ is a molecular switch that controls immune suppression.

artículo científico publicado en 2016

Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States

scientific article published on 29 January 2020

Current Treatment Options for Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

artículo científico

DNA repair biomarkers XPF and phospho-MAPKAP kinase 2 correlate with clinical outcome in advanced head and neck cancer

artículo científico publicado en 2014

Definitive chemoradiation for locally-advanced oral cavity cancer: A 20-year experience

scientific article published on 16 March 2018

Design of Phase II cancer trials for evaluation of cytostatic/cytotoxic agents

artículo científico publicado en 2009

Detection of tumor epidermal growth factor receptor pathway dependence by serum mass spectrometry in cancer patients

artículo científico publicado en 2010

Diarrhea associated with afatinib: an oral ErbB family blocker

artículo científico publicado en 2013

Diastolic Blood Pressure as a Biomarker of Axitinib Efficacy in Solid Tumors ⬇️

artículo científico publicado el 29 de abril de 2011

Disseminated follicular eruption during therapy with the MEK inhibitor AZD6244

artículo científico publicado en 2011

Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children

scientific article published on 23 July 2020

Editorial for special issue on nasopharynx cancer

artículo científico publicado en 2014

Effect of Adding Motolimod to Standard Combination Chemotherapy and Cetuximab Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck: The Active8 Randomized Clinical Trial

artículo científico publicado en 2018

Effects of vascular endothelial growth factor signaling inhibition on human erythropoiesis

artículo científico publicado en 2013

Efficacy and safety of treating T4 oral cavity tumors with primary chemoradiotherapy

artículo científico publicado en 2009

Epidermal growth factor receptor controls flat dysplastic aberrant crypt foci development and colon cancer progression in the rat azoxymethane model

artículo científico publicado en 2008

Epidermal growth factor receptor directed therapy in head and neck cancer

artículo científico publicado en 2005

Epidermal growth factor receptor inhibitor gefitinib added to chemoradiotherapy in locally advanced head and neck cancer

artículo científico publicado en 2010

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

artículo científico publicado en 2009

Erlotinib and the Risk of Oral Cancer: The Erlotinib Prevention of Oral Cancer (EPOC) Randomized Clinical Trial.

artículo científico publicado en 2015

Evaluation of food effect on pharmacokinetics of vismodegib in advanced solid tumor patients

artículo científico publicado en 2013

Evidence-based clinical practice guideline for the evaluation of potentially malignant disorders in the oral cavity: A report of the American Dental Association.

artículo científico publicado en 2017

Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas

artículo científico publicado en 2010

Evidence-based clinical recommendations regarding screening for oral squamous cell carcinomas

artículo científico publicado en 2012

Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab

artículo científico publicado en 2015

Factors associated with long-term speech and swallowing outcomes after chemoradiotherapy for locoregionally advanced head and neck cancer

artículo científico publicado en 2010

Final Results of a Randomized Phase 2 Trial Investigating the Addition of Cetuximab to Induction Chemotherapy and Accelerated or Hyperfractionated Chemoradiation for Locoregionally Advanced Head and Neck Cancer.

artículo científico publicado en 2016

Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib

scientific article published on August 2009

Forthcoming receptor tyrosine kinase inhibitors.

artículo científico publicado en 2006

Free-flap reconstruction in the doubly irradiated patient population

artículo científico publicado en 2008

Genetic profiling of advanced radioactive iodine-resistant differentiated thyroid cancer and correlation with axitinib efficacy.

artículo científico publicado en 2015

Germline polymorphisms discovered via a cell-based, genome-wide approach predict platinum response in head and neck cancers

artículo científico publicado en 2011

HPV16 E5 Mediates Resistance to PD-L1 Blockade and Can Be Targeted with Rimantadine in Head and Neck Cancer

scientific article published on 17 December 2019

High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial

artículo científico publicado en 2006

Hot topics issue: immunotherapy of cancer

scientific article published on 01 January 2008

Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics

scientific article published on 27 February 2019

Immunotherapeutic Approaches to the Management of Head and Neck Cancer

scientific article published on 01 December 2018

Immunotherapy of head and neck cancer: Emerging clinical trials from a National Cancer Institute Head and Neck Cancer Steering Committee Planning Meeting.

artículo científico publicado en 2016

Importance of Radiation Oncologist Experience Among Patients With Head-and-Neck Cancer Treated With Intensity-Modulated Radiation Therapy

artículo científico publicado en 2016

Induction chemotherapy and radiotherapy in locally advanced non-small cell lung cancer

artículo científico publicado en 2004

Integrated genomic analysis suggests MLL3 is a novel candidate susceptibility gene for familial nasopharyngeal carcinoma

artículo científico publicado en 2015

Integrative analysis of head and neck cancer identifies two biologically distinct HPV and three non-HPV subtypes

artículo científico publicado en 2014

Integrative and comparative genomic analysis of HPV-positive and HPV-negative head and neck squamous cell carcinomas

artículo científico publicado en 2014

Introduction: head and neck cancer

artículo científico publicado en 2008

Iodine-refractory thyroid carcinoma.

artículo científico publicado en 2006

Kawasaki Disease at 50 Years

artículo científico publicado en 2016

Laryngeal sarcoidosis: presentation and management in the pediatric population

artículo científico

Lenvatinib in Advanced, Radioactive Iodine-Refractory, Differentiated Thyroid Carcinoma

artículo científico publicado en 2015

Leveraging TCR Affinity in Adoptive Immunotherapy against Shared Tumor/Self-Antigens

artículo científico publicado en 2018

Measuring the development of integrative care communication patterns and cross-disciplinary knowledge at a university clinic: a baseline cross-sectional study.

artículo científico publicado en 2009

Mechanisms of and therapeutic approaches for overcoming resistance to epidermal growth factor receptor (EGFR)-targeted therapy in squamous cell carcinoma of the head and neck (SCCHN).

artículo científico publicado en 2015

MicroRNA-regulated feed forward loop network

artículo científico publicado en 2009

Modifiable risk behaviors in patients with head and neck cancer

artículo científico publicado en 2013

Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition ⬇️

artículo científico publicado el 14 de noviembre de 2012

Monitoring Daily Dynamics of Early Tumor Response to Targeted Therapy by Detecting Circulating Tumor DNA in Urine

artículo científico publicado en 2017

Multi-tiered genomic analysis of head and neck cancer ties TP53 mutation to 3p loss

artículo científico publicado en 2014

Multidisciplinary Care of Laryngeal Cancer

artículo científico publicado en 2016

Multidisciplinary care of the patient with head and neck cancer

artículo científico publicado en 2013

New strategies in head and neck cancer: understanding resistance to epidermal growth factor receptor inhibitors

artículo científico publicado en 2010

Novel molecular targeted therapies for refractory thyroid cancer ⬇️

artículo científico publicado el 4 de mayo de 2011

Novel targeted therapies in head and neck cancer ⬇️

artículo científico publicado el 12 de enero de 2012

Novel therapeutic targets in squamous cell carcinoma of the head and neck

artículo científico publicado en 2004

Open Access in biomedical sciences: what the current turning point means more specifically to Oral Oncology contributors and readers

scientific article published on 01 October 2013

PI3Kγ is a molecular switch that controls immune suppression

artículo científico publicado en 2016

Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study

artículo científico publicado en 2018

Performance and quality of life outcomes for T4 laryngeal cancer patients treated with induction chemotherapy followed by chemoradiotherapy ⬇️

artículo científico publicado el 22 de mayo de 2012

Pharmacoeconomic issues in head and neck oncology

artículo científico

Pharmacokinetics of single-agent axitinib across multiple solid tumor types.

artículo científico publicado en 2014

Phase I studies of sirolimus alone or in combination with pharmacokinetic modulators in advanced cancer patients

artículo científico publicado en 2012

Phase I study of bevacizumab added to fluorouracil- and hydroxyurea-based concomitant chemoradiotherapy for poor-prognosis head and neck cancer

artículo científico publicado en 2008

Phase I trial of tirapazamine, cisplatin, and concurrent accelerated boost reirradiation in patients with recurrent head and neck cancer

artículo científico publicado en 2007

Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands

article by Mark Agulnik et al published September 2007 in Journal of Clinical Oncology

Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements

scientific article published on 12 January 2012

Phase II study of gefitinib adaptive dose escalation to skin toxicity in recurrent or metastatic squamous cell carcinoma of the head and neck ⬇️

artículo científico publicado el 17 de abril de 2012

Phase II study of sunitinib malate in head and neck squamous cell carcinoma

artículo científico publicado en 2009

Phase II trial of ZD1839 in recurrent or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2003

Phase II trial of gefitinib 250 mg daily in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2005

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

artículo científico publicado en 2014

Phase III study of gefitinib compared with intravenous methotrexate for recurrent squamous cell carcinoma of the head and neck [corrected].

artículo científico publicado en 2009

Planned post-chemoradiation neck dissection: significance of radiation dose

scientific article published on 01 January 2006

Positive Surgical Margins in the 10 Most Common Solid Cancers.

artículo científico publicado en 2018

Precision Chemoradiotherapy for HER2 Tumors Using Antibody Conjugates of an Auristatin Derivative with Reduced Cell Permeability

scientific article published on 09 October 2019

Predictors of competing mortality in advanced head and neck cancer

artículo científico publicado en 2009

Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation ⬇️

artículo científico publicado el 13 de junio de 2011

Proceedings of the 2016 Childhood Arthritis and Rheumatology Research Alliance (CARRA) Scientific Meeting : Toronto, Canada. 14-17 April 2016

article

Prognostic Role of p16 in Nonoropharyngeal Head and Neck Cancer

artículo científico publicado en 2018

Protein kinase C zeta mediates epidermal growth factor-induced growth of head and neck tumor cells by regulating mitogen-activated protein kinase

artículo científico publicado en 2006

Quality of life scores as prognostic factors of overall survival in advanced head and neck cancer: Analysis of a phase III randomized trial of pemetrexed plus cisplatin versus cisplatin monotherapy ⬇️

artículo científico publicado el 11 de marzo de 2012

Race and competing mortality in advanced head and neck cancer

artículo científico publicado en 2013

Radiation Therapy Combined With Checkpoint Blockade Immunotherapy for Metastatic Undifferentiated Pleomorphic Sarcoma of the Maxillary Sinus With a Complete Response

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline

artículo científico publicado en 2017

Randomized phase II trial of cixutumumab alone or with cetuximab for refractory recurrent/metastatic head and neck squamous cell carcinoma

artículo científico publicado en 2018

Rare occurrence of EGFRvIII deletion in head and neck squamous cell carcinoma

artículo científico publicado en 2014

Rationale and design of LUX-Head & Neck 1: a randomised, Phase III trial of afatinib versus methotrexate in patients with recurrent and/or metastatic head and neck squamous cell carcinoma who progressed after platinum-based therapy

artículo científico publicado en 2014

Redirecting extracellular proteases to molecularly guide radiosensitizing drugs to tumors

artículo científico publicado en 2020

Reply to s. Chakraborty et al

artículo científico publicado en 2015

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

artículo científico publicado en 2005

Reviews on Recent Clinical Trials. Tyrosine kinases.

artículo científico publicado en 2007

Rising incidence of oral tongue cancer among white men and women in the United States, 1973-2012.

artículo científico

Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis

artículo científico publicado en 2017

Role of epidermal growth factor receptor pathway-targeted therapy in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2006

SUPREME-HN: a retrospective biomarker study assessing the prognostic value of PD-L1 expression in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck

artículo científico publicado en 2019

Safety and Efficacy of Pembrolizumab With Chemoradiotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Phase IB Study

artículo científico publicado en 2020

Searching for a standard

artículo científico publicado en 2002

Selection of Head and Neck Cancer Patients for Intensive Therapy

scientific article published on 30 September 2019

Serum C-Telopeptide Collagen Crosslinks and Plasma Soluble VEGFR2 as Pharmacodynamic Biomarkers in a Trial of Sequentially Administered Sunitinib and Cilengitide

artículo científico publicado en 2015

Serum antibodies open the door to prediction and prognostication in human papillomavirus-related head and neck cancer.

artículo científico publicado en 2017

Single sample expression-anchored mechanisms predict survival in head and neck cancer

artículo científico publicado en 2012

Sorafenib inhibits MAPK-mediated proliferation in a Barrett's esophageal adenocarcinoma cell line

artículo científico publicado en 2008

Stereotactic body radiotherapy for multisite extracranial oligometastases: final report of a dose escalation trial in patients with 1 to 5 sites of metastatic disease

artículo científico publicado en 2011

Stimuli-responsive magnetic nanomicelles as multifunctional heat and cargo delivery vehicles

artículo científico publicado en 2013

Study of functional infrared imaging for early detection of mucositis in locally advanced head and neck cancer treated with chemoradiotherapy

artículo científico publicado en 2013

Summary of the third World Congress on Thyroid Cancer

article

Survival and selected outcomes of older adults with locally advanced head/neck cancer treated with chemoradiation therapy

artículo científico publicado en 2013

Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

scientific article published on 05 December 2019

Talimogene Laherparepvec and Pembrolizumab in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (MASTERKEY-232): A Multicenter, Phase 1b Study

scientific article published on 15 July 2020

Targeted and Cytotoxic Therapy in Coordinated Sequence (TACTICS): Erlotinib, Bevacizumab, and Standard Chemotherapy for Non–Small-Cell Lung Cancer, A Phase II Trial

artículo científico publicado en 2011

Targeting angiogenesis in head and neck cancer

artículo científico publicado en 2008

Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck

artículo científico

The ACR appropriateness criteria® for thyroid carcinoma: searching for consensus in a rapidly evolving area.

artículo científico publicado en 2014

The Changing Landscape of Therapeutic Cancer Vaccines - Novel Platforms and Neoantigen Identification

artículo científico publicado en 2020

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma

artículo científico publicado en 2009

The Role of Chemotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma ⬇️

artículo científico publicado el 1 de julio de 2012

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

scientific article published on 15 July 2019

The effect of thalidomide on the pharmacokinetics of irinotecan and metabolites in advanced solid tumor patients ⬇️

artículo científico publicado el 23 de agosto de 2011

The expanding role of systemic therapy in head and neck cancer

artículo científico publicado en 2004

The future of induction chemotherapy for head and neck squamous cell carcinoma ⬇️

artículo científico publicado el 14 de septiembre de 2012

The next phase of chemoprevention research

artículo científico publicado en 2011

The rise of HPV-positive oropharyngeal cancers in the United States

artículo científico

Thrombolytic therapy for acute stroke in late pregnancy with intra-arterial recombinant tissue plasminogen activator

artículo científico publicado en 2005

Thyroid special issue

artículo científico publicado en 2013

Tipifarnib in recurrent, metastatic HRAS-mutant salivary gland cancer

scientific article published on 18 June 2020

Towards a personalized treatment of head and neck cancer

artículo científico

Treatment of advanced thyroid cancer with axitinib: Phase 2 study with pharmacokinetic/pharmacodynamic and quality-of-life assessments

artículo científico publicado en 2014

Treatment of squamous cell carcinoma of the head and neck in the metastatic and refractory settings: advances in chemotherapy and the emergence of small molecule epidermal growth factor receptor kinase inhibitors

artículo científico publicado en 2007

Two Drug Interaction Studies of Sirolimus in Combination with Sorafenib or Sunitinib in Patients with Advanced Malignancies ⬇️

artículo científico publicado el 29 de marzo de 2011

Vemurafenib in patients with BRAF(V600E)-positive metastatic or unresectable papillary thyroid cancer refractory to radioactive iodine: a non-randomised, multicentre, open-label, phase 2 trial

artículo científico publicado en 2016

[18F]Fluorodeoxyglucose positron emission tomography in the initial staging of squamous cell carcinoma of the head and neck: promise, evidence, and reality

artículo científico publicado en 2010

mTOR inhibitors.

artículo científico publicado en 2006

mTOR: the mammalian target of replication

artículo científico publicado en 2008

p16 status and choice of chemotherapy in the KEYNOTE-040 study - Authors' reply

artículo científico publicado en 2019

p62/SQSTM1 accumulation in squamous cell carcinoma of head and neck predicts sensitivity to phosphatidylinositol 3-kinase pathway inhibitors

artículo científico publicado en 2014

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda